Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : American Bio Medica (ABMC) drug test solution -taking off! -- Ignore unavailable to you. Want to Upgrade?

To: John Anderfuren who wrote (570)	1/13/2000 11:43:00 AM
From: Skywatcher	Read Replies (1) \| Respond to of 629

American Bio Medica Receives Patent in the UK KINDERHOOK, N.Y.--(BUSINESS WIRE)--Jan. 13, 2000--American Bio Medica Corp. (NASDAQ: ABMC - news) today reported that it received a patent for the Rapid Drug Screen(tm) drug abuse test kit in the United Kingdom. The patent covers the components of the Rapid Drug Screen test kit. ABMC believes that the testing process used in its on-site drug screen provides a distinct competitive advantage over competitors' products, which are not as easy to use or as effective. ABMC said that the UK patent further expands global protection for its on-site substance abuse tests and strengthens the market position of the Company's UK distributor. The Company received a similar patent from the U.S. Patent Office in November 1999. ABMC Chairman and CEO Stan Cipkowski commented, ''The UK patent further confirms the unique aspects of our Rapid Drug Screen products. We continue to capitalize upon these features and the competitive edge that they afford our on-site tests in the drug testing industry. I expect that the patent will generate positive results for our British distributor and that it will facilitate our efforts to rid the UK market of copycat products, thus further improving our positioning.'' The Rapid Drug Screen single-step tests for substances of abuse generate results in five minutes and are unrivaled for ease of use. The most secure and flexible total testing system on the market, ABMC's on-site tests simultaneously screen for the presence or absence of up to nine illicit drugs. American Bio Medica Corporation develops, manufactures and markets inexpensive, accurate,on-site drugs of abuse diagnostic kits and support services worldwide. The Company's global distributors target the workplace, clinical, physicians, corrections and educational markets. ABMC's Rapid Drug Screen is proven to correlate 100% with the standard laboratory screening test. chris